Part of Thermo Fisher Scientific
TREK Diagnostic Systems - Magellan Biosciences

 


Sitemap | Contact Info

  Products Technical Information Newsroom Company Information
Products
Trade Shows
Press Releases  
Newsletters  
Awards  
 

 

 

 
 
 

Press Releases

For Immediate Release
Date: November 28, 2006
Contact: Liz Lloyd, Marketing Communications Manager
Phone: 800.871.8909 ext. 109

TREK Diagnostic Systems Announces Change in Ownership

Cleveland, OH—November 28, 2006 –TREK Diagnostic Systems announced today that it has been acquired by Magellan Biosciences, Inc.

Under the terms of the acquisition, TREK Diagnostic Systems will function as a subsidiary of Magellan Biosciences, and will continue business under TREK Diagnostic Systems, Inc. The existing management team at TREK Diagnostic Systems will stay in place.

“Our acquisition by Magellan opens significant new opportunities for TREK Diagnostic Systems, its employees, and customers – providing expanded resources, and increasing our presence in the automated microbiology market,” Mike Burke, President of TREK Diagnostic Systems stated. “We look forward to pursuing synergies among our sister companies, notably the potential to bring world-class automation capabilities to our customers.”

TREK represents the largest acquisition by Magellan Biosciences to date.

About Magellan Biosciences, Inc.
Magellan serves the worldwide clinical-diagnostics market with rapid point-of-care analyzers and automated systems for hospital-based labs and near-patient testing. Scientists use the company’s discovery systems and sensors for cutting-edge research to develop a new understanding of health and illness – from disease pathology to biomarker identification. Magellan designs all its systems, sensors, and consumables to deliver better, more-reliable results. And better results help drive improved health outcomes: earlier, more-accurate diagnoses; breakthroughs that can lead to novel treatments, new cures – innovations to enhance life. A privately held company, Magellan serves customers through wholly owned subsidiaries: TREK Diagnostic Systems, ESA Biosciences, Dynex Technologies, and TekCel.

Headquartered about 30 miles northwest of Boston in Chelmsford, Massachusetts, Magellan employs a talented, multidisciplinary staff of approximately 310 worldwide who work cross-functionally to provide quick response to customers and to solve complex product-development and technical-support problems. For more information, visit www.magellanbio.com

About TREK Diagnostic Systems
TREK Diagnostic Systems is a global manufacturer and distributor of automated systems and consumable products for microbiology diagnostic testing serving the clinical, pharmaceutical, and veterinary laboratory markets. Signature product lines, the VersaTREK® Automated Microbial Detection System and the Sensititre® Automated Susceptibility and Identification Testing System, are designed to provide cost effective improvements in workflow efficiencies, ergonomics, and test result performance.  For more information, visit  www.trekds.com.

For more information, contact Liz Lloyd at 216.485.1140 or via e-mail at elloyd@trekds.com

###

< back

 

Sitemap | Privacy Policy | Terms & Conditions | © TREK Diagnostic Systems